784 related articles for article (PubMed ID: 6602840)
1. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population.
Finkelman FD; Mond JJ; Metcalf ES
J Immunol; 1983 Aug; 131(2):593-600. PubMed ID: 6602840
[TBL] [Abstract][Full Text] [Related]
2. Effects of neonatal anti-delta antibody treatment on the murine immune system. II. Functional capacity of a stable sIgM+sIa+sIgD- B cell population.
Metcalf ES; Mond JJ; Finkelman FD
J Immunol; 1983 Aug; 131(2):601-5. PubMed ID: 6602841
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the clonal diversity of the B cell repertoires in adult mice that differ in the expression of cell surface IgD.
Fultz MJ; Finkelman FD; Metcalf ES
Eur J Immunol; 1987 Aug; 17(8):1137-43. PubMed ID: 3113979
[TBL] [Abstract][Full Text] [Related]
4. Polyclonal activation of the murine immune system by an antibody to IgD. X. Evidence that the precursors of IgG1-secreting cells are newly generated membrane IgD+B cells rather than the B cells that are initially activated by anti-IgD antibody.
Finkelman FD; Goroff DK; Fultz M; Morris SC; Holmes JM; Mond JJ
J Immunol; 1990 Dec; 145(11):3562-9. PubMed ID: 2246501
[TBL] [Abstract][Full Text] [Related]
5. Polyclonal activation of the murine immune system by an antibody to IgD. VIII. Stimulation of IgD secretion.
Mountz JD; Smith J; Snapper CM; Mushinski JF; Finkelman FD
J Immunol; 1987 Oct; 139(7):2172-8. PubMed ID: 3498752
[TBL] [Abstract][Full Text] [Related]
6. Development of B lymphocytes in the mouse; studies of the frequency and distribution of surface IgM and IgD in normal and immune-defective CBA/N F1 mice.
Scher I; Berning AK; Kessler S; Finkelman FD
J Immunol; 1980 Oct; 125(4):1686-93. PubMed ID: 6997384
[TBL] [Abstract][Full Text] [Related]
7. Polyclonal activation of the murine immune system by an antibody to IgD. VI. Influence of doses of goat anti-mouse delta chain and normal goat IgG on B lymphocyte proliferation and differentiation.
Finkelman FD; Smith J; Villacreses N; Metcalf ES
Eur J Immunol; 1985 Apr; 15(4):315-20. PubMed ID: 3157578
[TBL] [Abstract][Full Text] [Related]
8. Polyclonal activation of the murine immune system by an antibody to IgD V. Effect on germinal centers.
Flotte TJ; Finkelman FD; Thorbecke GJ
Eur J Immunol; 1984 Aug; 14(8):725-8. PubMed ID: 6332026
[TBL] [Abstract][Full Text] [Related]
9. Production of BSF-1 during an in vivo, T-dependent immune response.
Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
Goroff DK; Stall A; Mond JJ; Finkelman FD
J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
[TBL] [Abstract][Full Text] [Related]
11. Polyclonal activation of the murine immune system by an antibody to IgD. III. Ontogeny.
Muul LM; Mond JJ; Finkelman FD
Eur J Immunol; 1983 Nov; 13(11):900-5. PubMed ID: 6605861
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice.
Muul LM; Scher I; Mond JJ; Finkelman FD
J Immunol; 1983 Nov; 131(5):2226-31. PubMed ID: 6605378
[TBL] [Abstract][Full Text] [Related]
13. Cell surface phenotype of lymphoid cells from normal mice and mice treated with monoclonal anti-IgD from birth.
Skelly RR; Baine Y; Ahmed A; Xue B; Thorbecke GJ
J Immunol; 1983 Jan; 130(1):15-8. PubMed ID: 6600173
[TBL] [Abstract][Full Text] [Related]
14. Endogenous expression of delta on the surface of WEHI-231. Characterization of its expression and signaling properties.
Haggerty HG; Wechsler RJ; Lentz VM; Monroe JG
J Immunol; 1993 Nov; 151(9):4681-93. PubMed ID: 8409428
[TBL] [Abstract][Full Text] [Related]
15. Polyclonal activation of the murine immune system by an antibody to IgD. VII. Demonstration of the role of nonantigen-specific T help in in vivo B cell activation.
Finkelman FD; Smith J; Villacreses N; Metcalf ES
J Immunol; 1984 Aug; 133(2):550-5. PubMed ID: 6203966
[TBL] [Abstract][Full Text] [Related]
16. B-cell production and differentiation in adult rats.
Bazin H; Platteau B; Maclennan IC; Johnson GD
Immunology; 1985 Jan; 54(1):79-88. PubMed ID: 3871730
[TBL] [Abstract][Full Text] [Related]
17. Maturation of B lymphocytes. II. Sequential appearance of increasing IgM and IgD in the adult bone marrow.
Lala PK; Layton JE; Nossal GJ
Eur J Immunol; 1979 Jan; 9(1):39-44. PubMed ID: 374092
[TBL] [Abstract][Full Text] [Related]
18. Physiology of Igd. II. Lack of humoral immune responsiveness in lymph nodes of mice treated with anti-IgD from birth.
Baine Y; Chen YW; Jacobson EB; Pernis B; Siskind GW; Thorbecke GJ
Eur J Immunol; 1982 Oct; 12(10):882-6. PubMed ID: 6983443
[TBL] [Abstract][Full Text] [Related]
19. Surface immunoglobulin phenotype of complement receptor-positive and complement receptor-negative B cells of normal and xid immunodeficient mice.
Lindsten T; Finkelman FD; Thompson CB; Andersson B; Scher I
Eur J Immunol; 1984 Apr; 14(4):329-35. PubMed ID: 6609823
[TBL] [Abstract][Full Text] [Related]
20. B-Cell suppression in adult mice injected with anti-delta followed by anti-mu mAb.
Chentoufi AA; Nizet Y; Havaux X; Nisol F; Bazin H; Latinne D
Cell Immunol; 2000 Oct; 205(1):40-51. PubMed ID: 11078606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
